<DOC>
	<DOCNO>NCT01616485</DOCNO>
	<brief_summary>The objective study evaluate hemodynamic response sublingual dose glyceryl trinitrate subject receive oral TA-1790 , sildenafil citrate , placebo .</brief_summary>
	<brief_title>Study Evaluate Hemodynamic Response Sublingual Dose Glyceryl Trinitrate Subjects Receiving TA-1790 , Sildenafil Citrate , Placebo</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<mesh_term>Nitroglycerin</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Provide write informed consent Willing comply study requirement clinic schedule Male 30 60 year age Nonsmoker No history alcohol abuse Normal screen laboratory value Allergy hypersensitive PDE5 inhibitor Evidence clinically significant disease Supine systolic/diastolic blood pressure level History cardiovascular disease Previously participate TA1790 within past 30 day</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>